3-Oxo-1-phenyl-2,7,10-trioxa-4-azadodecan-12-yl 4-methylbenzenesulfonate

Catalog No. :
ACTQSY452
CAS No. :
2098983-15-2
Molecular Formula :
C21H27NO7S
Molecular Weight :
437.51

IUPAC Name:3-oxo-1-phenyl-2,7,10-trioxa-4-azadodecan-12-yl 4-methylbenzenesulfonate

3-Oxo-1-phenyl-2,7,10-trioxa-4-azadodecan-12-yl 4-methylbenzenesulfonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$85.00Login to see priceIn stockInquiry
250mg95%$193.00Login to see priceIn stockInquiry
1g95%$566.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Oxo-1-phenyl-2,7,10-trioxa-4-azadodecan-12-yl 4-methylbenzenesulfonate
IUPAC Name3-oxo-1-phenyl-2,7,10-trioxa-4-azadodecan-12-yl 4-methylbenzenesulfonate
MDL No.MFCD34179126
Molecular FormulaC21H27NO7S
Molecular Weight437.51
SMILESO=S(C1=CC=C(C)C=C1)(OCCOCCOCCNC(OCC2=CC=CC=C2)=O)=O
InChI KeyMVOVZYARJJDYFD-UHFFFAOYSA-N
SynonymCarbamic acid, N-[2-[2-[2-[[(4-methylphenyl)sulfonyl]oxy]ethoxy]ethoxy]ethyl]-, phenylmethyl ester
CAS No.2098983-15-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACTQSY452 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLCWZ781 route compound structure diagram
    ACLCWZ781205535-92-8 In Stock
  2. Then
  3. ACTQSY452 route product structure diagram
    ACTQSY4522098983-15-2 In Stock
Inquiry

2. ACTQSY452 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLCWZ781 route compound structure diagram
    ACLCWZ781205535-92-8 In Stock
  4. Then
  5. ACTQSY452 route product structure diagram
    ACTQSY4522098983-15-2 In Stock
Inquiry

Comments (0)